0001225208-22-006817.txt : 20220510 0001225208-22-006817.hdr.sgml : 20220510 20220510205447 ACCESSION NUMBER: 0001225208-22-006817 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220507 FILED AS OF DATE: 20220510 DATE AS OF CHANGE: 20220510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wood Larry L CENTRAL INDEX KEY: 0001440660 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 22911786 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0306 4 2022-05-07 0001099800 Edwards Lifesciences Corp EW 0001440660 Wood Larry L ONE EDWARDS WAY IRVINE CA 92614 1 CVP, TAVR Common Stock 2022-05-07 4 F 0 679.0000 100.5200 D 200820.0338 D Common Stock 2022-05-08 4 M 0 13256.0000 0 A 214076.0338 D Common Stock 2022-05-08 4 F 0 8007.0000 100.5200 D 206069.0338 D Common Stock 2022-05-10 4 M 0 7242.0000 36.7500 A 213311.0338 D Common Stock 2022-05-10 4 S 0 2674.0000 95.7106 D 210637.0338 D Common Stock 2022-05-10 4 S 0 4568.0000 96.3771 D 206069.0338 D Common Stock 495.8921 I 401(k) Performance Rights 2022-05-08 4 M 0 13256.0000 0.0000 D 2022-05-08 2026-05-07 Common Stock 13256.0000 0.0000 D Employee Stock Option (Right to Acquire) 36.7500 2022-05-10 4 M 0 7242.0000 0.0000 D 2018-05-11 2024-05-10 Common Stock 7242.0000 50688.0000 D On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021. This transaction was executed in multiple trades at prices ranging from $95.16 to $96.14. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $96.18 to $96.60. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2022-05-10